|
R&D Systems
α5 gabaar α5 Gabaar, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/c+terminus/Mouse%2FRat+GABA-A+R+alpha+5+C-Terminus+Antibody/pm42776198-92-8-12 Average 92 stars, based on 1 article reviews
α5 gabaar - by Bioz Stars,
2026-11
92/100 stars
|
Buy from Supplier |
|
NeuroMab
mouse monoclonal anti total lrrk2 mouse ![]() Mouse Monoclonal Anti Total Lrrk2 Mouse, supplied by NeuroMab, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/c+terminus/Anti-LRRK2%2FDardarin%2C+C-Terminus+Antibody/med_rxiv__64898__2026__08__21__26358613-55-0-5 Average 95 stars, based on 1 article reviews
mouse monoclonal anti total lrrk2 mouse - by Bioz Stars,
2026-11
95/100 stars
|
Buy from Supplier |
|
NeuroMab
lrrk2 ![]() Lrrk2, supplied by NeuroMab, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/c+terminus/Anti-LRRK2%2FDardarin%2C+C-Terminus+Antibody/pmc13724748-489-7-9 Average 95 stars, based on 1 article reviews
lrrk2 - by Bioz Stars,
2026-11
95/100 stars
|
Buy from Supplier |
|
Sangon Biotech
c terminus ![]() C Terminus, supplied by Sangon Biotech, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/c+terminus/c+terminus/pm42265791-85-21-26 Average 86 stars, based on 1 article reviews
c terminus - by Bioz Stars,
2026-11
86/100 stars
|
Buy from Supplier |
|
RayBiotech inc
goat anti human cystatin b stefin b ![]() Goat Anti Human Cystatin B Stefin B, supplied by RayBiotech inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/c+terminus/Goat+Anti-Human+Cystatin+b+%2F+Stefin+B+(C-Terminus)/us12631655-302-26-34 Average 94 stars, based on 1 article reviews
goat anti human cystatin b stefin b - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
Boster Bio
crp ![]() Crp, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/c+terminus/Anti-HDAC-2+(C-terminus)+Antibody/pmc13131401-117-12-36 Average 93 stars, based on 1 article reviews
crp - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Pacific Immunology
anti c terminus antibody ![]() Anti C Terminus Antibody, supplied by Pacific Immunology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/c+terminus/anti+c+terminus/pmc13162661-115-16-18 Average 86 stars, based on 1 article reviews
anti c terminus antibody - by Bioz Stars,
2026-11
86/100 stars
|
Buy from Supplier |
|
Boster Bio
myeloperoxidase mpo ![]() Myeloperoxidase Mpo, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/c+terminus/Anti-HDAC-2+(C-terminus)+Antibody/pmc13131401-117-14-36 Average 93 stars, based on 1 article reviews
myeloperoxidase mpo - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Boster Bio
histone deacetylase 2 ![]() Histone Deacetylase 2, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/c+terminus/Anti-HDAC-2+(C-terminus)+Antibody/pmc13131401-117-7-36 Average 93 stars, based on 1 article reviews
histone deacetylase 2 - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Boster Bio
interleukin 6 ![]() Interleukin 6, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/c+terminus/Anti-HDAC-2+(C-terminus)+Antibody/pmc13131401-117-5-36 Average 93 stars, based on 1 article reviews
interleukin 6 - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
Journal: medRxiv
Article Title: The VPS35 p.A320V variant segregates with Parkinson’s disease in a pesticide-exposed family
doi: 10.64898/2026.08.21.26358613
Figure Lengend Snippet: A) Summary of donor participants; neutrophils and monocytes were isolated from six members of the affected family, including 1 VPS35 p.A320V carrier with PD (individual III.3), four NMC VPS35 p.A320V (individuals IV.2, IV.5, IV.6, and V.1), and one non-variant carrier (individual IV.7). An additional four un-related, non-mutation carriers were also included as controls (individuals D01, D02, D03, and D04). A-B) Immunoblot analysis was performed with 20 μg of protein from neutrophil and monocyte samples. Neutrophils and monocytes were treated with a LRRK2-specific small-molecule inhibitor, MLi2 (200 nM), or a vehicle control for 30 minutes prior to lysis. C-F) Quantification of LRRK2 activity with neutrophils and monocytes by immunoblot analysis and targeted mass spectrometry (MS). PT73-Rab10 levels / total Rab10 levels were normalized to the average of non-carrier (vehicle-treated control) samples. LRRK2 activity was reported as fold-change relative to the average of non-carrier (vehicle-treated controls) samples. Data were analy z ed using Welch’s t-test. pT73-Rab10 levels were not significantly elevated in neutrophils or monocytes collected from A320V mutation carriers (n=5) compared to non-mutation carriers (n=5).
Article Snippet:
Techniques: Isolation, Variant Assay, Mutagenesis, Western Blot, Control, Lysis, Activity Assay, Mass Spectrometry
Journal: NPJ Parkinson's Disease
Article Title: Interaction of G2019S LRRK2 and metabolic syndrome in a two-hit mouse model of Parkinson’s disease: LRRK2-driven systemic depletion of pyrimidine nucleosides
doi: 10.1038/s41531-026-01465-x
Figure Lengend Snippet: a Schematic diagram of the experimental design. Mice were fed with normal chow diet (23.7% Kcal from fat) for 11 months, then they were randomly divided into high-fat diet (60% Kcal from fat) or control diet (10% Kcal from fat) groups, the mice were kept on their specific diets for an additional five months. Behavioral tests were conducted before the diet switch and again four months afterward. Body weight was measured biweekly. Fasting blood glucose and plasma insulin levels were measured two weeks prior to euthanasia. At the age of 16 months old, plasma, brain, liver, lung, and kidney were collected and subjected to biochemical and histological analysis. b Body weight changes along with 20 weeks of specific diet feeding ( n = 10–14 per group). c Blood glucose and d Plasma insulin level at 20 weeks post specific diet feeding ( n = 10–14 per group). e , f Volcano plot showing differences in the abundance of lipids between HFD and Con.diet in the plasma of G2019S LRRK2 knockin mice and wild-type controls, each point represents a lipid species. X-axis shows log 2 (fold change) in lipid abundance between high-fat diet and control diet groups. Y-axis shows −log 10 (adjusted p -value) from limma’s empirical Bayes moderated analysis (eBayes) combined with Benjamini–Hochberg (BH) for multiple testing correction ( n = 6 per group). Lipids with adjusted P < 0.05 are considered significantly altered. Significantly upregulated lipids are highlighted in red and significantly downregulated lipids are highlighted in blue. g Representative images of Hematoxylin and Eosin (H&E) staining of the livers collected at the terminal stage, scale bar: 100 µm. h Quantification of lipid area in H&E-stained liver sections ( n = 3–4 per group). WT/WT, wild-type mice; KI/KI, homozygous G2019S LRRK2 knockin mice; TG, triglycerides; LPC, lysophosphatidylcholine. Data are presented as mean ± SEM. A two-way ANOVA was performed to evaluate the effects of high-fat diet and G2019S LRRK2 mutant and their interaction followed by Fisher’s LSD comparisons. Significant main effects were found (* P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001).
Article Snippet: Primary antibodies used for Western blotting include:
Techniques: Control, Clinical Proteomics, Analysis, Knock-In, Staining, Mutagenesis
Journal: NPJ Parkinson's Disease
Article Title: Interaction of G2019S LRRK2 and metabolic syndrome in a two-hit mouse model of Parkinson’s disease: LRRK2-driven systemic depletion of pyrimidine nucleosides
doi: 10.1038/s41531-026-01465-x
Figure Lengend Snippet: Behavioral tests were conducted four months after the initiation of diet switch ( n = 5–8 per group). a – d Open field test. a Scheme and dimensions of the open field apparatus; b Total distance traveled (m) during the 15-min open field test; c Distance traveled in center zone of total distance of the open field test during 15-min session; d Entries in central zone (frequency) during the 15-min open field test. e – l Catwalk gait analysis. e Average speed (cm/s); f – i Stand time of each paw (s), LF, left front; RF, right front; LH, left hind; RF, right hind. j Cadence (steps/s); k , i Base of support; m – p Elevated plus maze. m Scheme and annotation of the elevated plus maze apparatus; n Time spend (s) in open arm of elevated plus maze during the 10-min test; o Entries in open arms (frequency) of elevated plus maze during the 10-min test; p Ratio of distance traveled in the open arms and center zone relative to the total distance during the elevated plus maze. q , r Y-maze. q Scheme and annotation of the Y-maze apparatus; r Spontaneous alternation (%) calculated in the 10-min Y-maze test. WT/WT, wild-type mice; KI/KI, homozygous G2019S LRRK2 knockin mice. Data are presented as mean ± SEM. A two-way ANOVA was performed to evaluate the effects of high-fat diet and G2019S LRRK2 mutant and their interaction followed by Fisher’s LSD comparisons. Significant main effects were found (* P < 0.05, ** P < 0.01).
Article Snippet: Primary antibodies used for Western blotting include:
Techniques: Open Field Test, Gait and locomotion, EPM Assay, Knock-In, Mutagenesis
Journal: NPJ Parkinson's Disease
Article Title: Interaction of G2019S LRRK2 and metabolic syndrome in a two-hit mouse model of Parkinson’s disease: LRRK2-driven systemic depletion of pyrimidine nucleosides
doi: 10.1038/s41531-026-01465-x
Figure Lengend Snippet: a , d , g Representative images of Iba1 immunostaining in the striatum ( a ), substantia nigra ( d ), and hypothalamus ( g ) showing microglial distribution. Scale bar: 100 µm. b , e , h Quantification of Iba1-positive microglial counts relative to area in the striatum ( b ), substantia nigra ( e ), and hypothalamus ( h ). c , f , i Quantification of average microglial soma area (µm²) in the striatum ( c ), substantia nigra ( f ), and hypothalamus ( i ) ( n = 5–6 per group). j Representative images of GFAP immunostaining in the hypothalamus showing astrocytes distribution. Scale bar: 100 µm. k Quantification of GFAP-positive area in the hypothalamus ( n = 5–6 per group). WT/WT, wild-type mice; KI/KI, homozygous G2019S LRRK2 knockin mice. Data are presented as mean ± SEM. A two-way ANOVA was performed to evaluate the effects of high-fat diet and G2019S LRRK2 mutant and their interaction followed by Fisher’s LSD comparisons. Significant main effects were found (* P < 0.05, ** P < 0.01).
Article Snippet: Primary antibodies used for Western blotting include:
Techniques: Immunostaining, Knock-In, Mutagenesis
Journal: NPJ Parkinson's Disease
Article Title: Interaction of G2019S LRRK2 and metabolic syndrome in a two-hit mouse model of Parkinson’s disease: LRRK2-driven systemic depletion of pyrimidine nucleosides
doi: 10.1038/s41531-026-01465-x
Figure Lengend Snippet: a Representative image of TH immunostaining in the substantia nigra. Scale bar: 500 µm. Quantification of TH-positive neurons ( b ) and Nissl-positive neurons ( c ) in the substantia nigra ( n = 3–7 per group). d Representative images of TH immunostaining in the striatum. Scale bar: 100 µm. e Quantification of TH-positive area in the striatum ( n = 5–6 per group). f Relative striatal dopamine level measured by LC-MS ( n = 5–6 per group). Western blot analysis ( g , h ) and quantification ( i – n ) of LRRK2 and Rab12 expression levels in the striatum ( g , i – k ) and ventral midbrain ( h , l – n ) of G2019S LRRK2 knockin and wild-type mice under control (Con.) diet and HFD conditions ( n = 3 per group). Data are presented as mean ± SEM. A two-way ANOVA was performed to evaluate the effects of high-fat diet and G2019S LRRK2 mutant and their interaction followed by Fisher’s LSD comparisons. WT/WT, wild-type mice; KI/KI, homozygous G2019S LRRK2 knockin mice. Data are presented as mean ± SEM. A two-way ANOVA was performed to evaluate the effects of high-fat diet and G2019S LRRK2 mutant and their interaction followed by Fisher’s LSD comparisons. Significant main effects were found (* P < 0.05, ** P < 0.01, *** P < 0.001).
Article Snippet: Primary antibodies used for Western blotting include:
Techniques: Immunostaining, Liquid Chromatography with Mass Spectroscopy, Western Blot, Analysis, Expressing, Knock-In, Control, Mutagenesis
Journal: NPJ Parkinson's Disease
Article Title: Interaction of G2019S LRRK2 and metabolic syndrome in a two-hit mouse model of Parkinson’s disease: LRRK2-driven systemic depletion of pyrimidine nucleosides
doi: 10.1038/s41531-026-01465-x
Figure Lengend Snippet: Volcano plot showing differences in the abundance of non-lipid metabolites between G2019S LRRK2 knockin mice and wild-type controls under Con.diet and HFD in the striatum ( a , b ), plasma ( c , d ), liver ( e , f ), lung ( g , h) , and kidney ( i , j ). WT/WT, wild-type mice; KI/KI, homozygous G2019S LRRK2 knockin mice. Each point represents a non-lipid metabolite. X-axis shows log 2 (fold change) in non-lipid metabolite abundance between G2019S LRRK2 knockin mice and wild-type controls. Y-axis shows −log 10 (adjusted p -value) from limma’s empirical Bayes moderated analysis (eBayes) combined with Benjamini–Hochberg (BH) for multiple testing correction ( n = 6 per group). Non-lipid metabolites with adjusted P < 0.05 are considered significantly altered. Significantly upregulated ones are highlighted in red and significantly downregulated ones are highlighted in blue.
Article Snippet: Primary antibodies used for Western blotting include:
Techniques: Knock-In, Clinical Proteomics, Analysis, Significance Assay
Journal: NPJ Parkinson's Disease
Article Title: Interaction of G2019S LRRK2 and metabolic syndrome in a two-hit mouse model of Parkinson’s disease: LRRK2-driven systemic depletion of pyrimidine nucleosides
doi: 10.1038/s41531-026-01465-x
Figure Lengend Snippet: Thymidine ( a ), deoxyuridine ( b ), deoxycytidine ( c ), deoxyadenosine ( d ), and deoxyguanine ( e ) concentrations in striatum (ng/g). Thymidine ( f ), deoxyuridine ( g ), deoxycytidine ( h ), deoxyadenosine ( i ), and deoxyguanine ( j ) concentrations in ventral midbrain (ng/g). Thymidine ( k ), deoxyuridine ( l ), and deoxycytidine ( m ) concentrations in plasma (ng/ml). Nucleoside quantity was measured by LC-MS ( n = 8–9 per group). Data are presented as mean ± SEM. Unpaired two-tailed Student’s t -test was performed to evaluate the effects of G2019S LRRK2 mutation (* P < 0.05, *** P < 0.001, **** P < 0.0001).
Article Snippet: Primary antibodies used for Western blotting include:
Techniques: Clinical Proteomics, Liquid Chromatography with Mass Spectroscopy, Two Tailed Test, Mutagenesis
Journal: NPJ Parkinson's Disease
Article Title: Interaction of G2019S LRRK2 and metabolic syndrome in a two-hit mouse model of Parkinson’s disease: LRRK2-driven systemic depletion of pyrimidine nucleosides
doi: 10.1038/s41531-026-01465-x
Figure Lengend Snippet: a – f Bar plot showing comparation of selected metabolites (relative abundance) in the striatum across groups ( n = 5–6 per group). These metabolites reflect alterations in energy metabolism ( a – c ) and nucleotide metabolism ( c – f ). Data are presented as mean ± SEM. A two-way ANOVA was performed to evaluate the effects of high-fat diet and G2019S LRRK2 mutant and their interaction, Tukey’s post hoc test was used for multiple comparisons. Significant main and interaction effects were found (* P < 0.05, ** P < 0.01, *** P < 0.001). g , h Volcano plot showing differential gene expression in the striatum between G2019S LRRK2 knockin and wild-type mice under Con.diet and HFD conditions. Each point represents one gene. X-axis shows log 2 (fold change) in gene expression, Y-axis shows −log 10 (adjusted p -value), significance was defined as a Benjamini–Hochberg adjusted P < 0.05 ( n = 4 per group). Gene expression with adjusted P < 0.05 are considered significantly altered. Significantly downregulated genes are highlighted in blue. i , j Volcano plot illustrates enriched biological processes between G2019S LRRK2 knockin and wild-type mice under Con.diet and HFD conditions as identified by gene set enrichment analysis (GSEA). Each point represents one process, X-axis shows normalized enrichment score, Y-axis shows -log 10 (adjusted p -value), significance was defined as a Benjamini–Hochberg adjusted P < 0.05 ( n = 4 per group). Significantly upregulated genes are highlighted in red and significantly downregulated genes are highlighted in blue. WT/WT, wild-type mice; KI/KI, homozygous G2019S LRRK2 knockin mice.
Article Snippet: Primary antibodies used for Western blotting include:
Techniques: Mutagenesis, Gene Expression, Knock-In, Gene Set Enrichment Analysis
Journal: NPJ Parkinson's Disease
Article Title: Interaction of G2019S LRRK2 and metabolic syndrome in a two-hit mouse model of Parkinson’s disease: LRRK2-driven systemic depletion of pyrimidine nucleosides
doi: 10.1038/s41531-026-01465-x
Figure Lengend Snippet: Nuclei were isolated from ventral midbrain of G2019S LRRK2 knockin mice and their littermates ( n = 4 per group), 34,969 nuclei were recovered in total. a t -SNE map shows 27 classified cell clusters with annotations. b Violin plot shows Lrrk2 expression across clusters. c Heatmap illustrates oxidative phosphorylation pathway enrichment across multiple cell types in various group comparisons. Each square represents a specific comparison (labeled on the right) within a given cell cluster (labeled at the bottom). Red squares indicate positive enrichment scores; blue squares indicate negative enrichment scores. Comparisons with statistically significant (Benjamini–Hochberg adjusted p ) enrichment are marked with stars (* P < 0.05, ** P < 0.01, **** P < 0.0001). WT/WT, wild-type mice; KI/KI, homozygous G2019S LRRK2 knockin mice.
Article Snippet: Primary antibodies used for Western blotting include:
Techniques: Isolation, Knock-In, Expressing, Phospho-proteomics, Comparison, Labeling
Journal: NPJ Parkinson's Disease
Article Title: Interaction of G2019S LRRK2 and metabolic syndrome in a two-hit mouse model of Parkinson’s disease: LRRK2-driven systemic depletion of pyrimidine nucleosides
doi: 10.1038/s41531-026-01465-x
Figure Lengend Snippet: a Diagram showing that thymidine phosphorylase catalyzes the conversion of thymidine and deoxyuridine into their respective bases (thymine and uracil) and 2-deoxyribose 1-phosphate. b Western blot analysis of thymidine phosphorylase (TP) expression levels in brain and liver in 5-month-old G2019S LRRK2 knockin mice and controls ( n = 2 per group). c qRT-PCR analysis of TYMP levels in ventral midbrain of 5-month-old G2019S LRRK2 knockin mice and controls ( n = 4 per group). Data are presented as mean ± SEM. Unpaired two-tailed Student’s t -test was performed to evaluate the effects of G2019S LRRK2 mutation, no significant effect was found. d Volcano plot showing differential gene expression in the liver of 5-month-old G2019S LRRK2 knockin mice compared to wild-type controls. Each point represents one gene. X-axis shows log 2 (fold change) in gene expression in G2019S LRRK2 knockin mice compared to wild-type controls. Y-axis shows −log 10 (adjusted p -value) from limma’s empirical Bayes moderated analysis (eBayes) combined with Benjamini–Hochberg (BH) for multiple testing correction ( n = 4 per group). Gene expression with adjusted P < 0.05 are considered significantly altered. Significantly upregulated genes are highlighted in red and significantly downregulated genes are highlighted in blue. e Volcano plot illustrating enriched biological processes in G2019S LRRK2 knockin mice compared to wild-type controls as identified by gene set enrichment analysis (GSEA). Each point represents one process. X-axis shows normalized enrichment score, Y-axis shows −log 10 (adjusted p -value), significance was defined as a Benjamini–Hochberg adjusted P < 0.05 ( n = 4 per group). Sig n ificantly upregulated pathways are highlighted in red and significantly downregulated pathways are highlighted in blue. f Western blot analysis and quantification ( g – m ) of TP, total and phosphorylated LRRK2, Rab10, and Rab12 expression levels in the liver of G2019S LRRK2 knockin and wild-type mice under Con.diet and HFD conditions ( n = 3 per group). WT/WT, wild-type mice; KI/KI, homozygous G2019S LRRK2 knockin mice. Data are presented as mean ± SEM. A two-way ANOVA was performed to evaluate the effects of high-fat diet and G2019S LRRK2 mutant and their interaction followed by Fisher’s LSD comparisons. Significant main effects were found (* P < 0.05, ** P < 0.01).
Article Snippet: Primary antibodies used for Western blotting include:
Techniques: Western Blot, Analysis, Expressing, Knock-In, Quantitative RT-PCR, Two Tailed Test, Mutagenesis, Gene Expression, Gene Set Enrichment Analysis
Journal: NPJ Parkinson's Disease
Article Title: Interaction of G2019S LRRK2 and metabolic syndrome in a two-hit mouse model of Parkinson’s disease: LRRK2-driven systemic depletion of pyrimidine nucleosides
doi: 10.1038/s41531-026-01465-x
Figure Lengend Snippet: a Schematic diagram showing central energy and biosynthetic pathways involving glucose and fatty acids. b – p Bar plot showing comparison of selected metabolites (relative abundance) in lung tissue from G2019S LRRK2 knockin and control mice exposed to either HFD or control diet ( n = 6 mice/group). These metabolites reflect alterations in glycolysis ( b , c ), TCA cycle ( d , e ), pentose phosphate pathway ( f – j ), and nucleotide metabolism ( k – p ). Data are presented as mean ± SEM in bar plot. A two-way ANOVA was performed to evaluate the effects of high-fat diet and G2019S LRRK2 and their interaction, Tukey’s post hoc test was used for multiple comparisons. Significant main and interaction effects were found (* P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001).
Article Snippet: Primary antibodies used for Western blotting include:
Techniques: Comparison, Tissue, Knock-In, Control
Journal: NPJ Parkinson's Disease
Article Title: Interaction of G2019S LRRK2 and metabolic syndrome in a two-hit mouse model of Parkinson’s disease: LRRK2-driven systemic depletion of pyrimidine nucleosides
doi: 10.1038/s41531-026-01465-x
Figure Lengend Snippet: a – c Representative images of H&E staining ( a ), CD68 ( b ), and CD3 ( c ) immunostaining of the lungs. Scale bar: 100 µm. d – g Volcano plot showing differences in the abundance of proteins between HFD and Con.diet groups in wild-type mice ( d ) and G2019S LRRK2 knockin mice ( e ); between G2019S LRRK2 knockin and wild-type mice under Con.diet ( f ) and HFD ( g ) conditions ( n = 4 mice/group). Each point represents a protein. X-axis shows log 2 fold change in protein abundance between each comparison. Y-axis shows −log 10 adjusted p -value from limma’s empirical Bayes moderated analysis (eBayes) combined with Benjamini–Hochberg (BH) for multiple testing correction ( n = 4 mice/group). Proteins with adjusted P < 0.05 are considered significantly altered. Significantly upregulated proteins are highlighted in red and significantly downregulated proteins are highlighted in blue. h Western blot analysis and quantification ( i – o ) of total and phosphorated LRRK2, Rab8a, Rab10, and Rab12 expression levels in the lung of G2019S LRRK2 knockin and wild-type mice under Con.diet and HFD conditions ( n = 3 mice/group). WT/WT, wild - type mice; KI/KI, homozygous G2019S LRRK2 knockin mice. Data are presented as mean ± SEM. A two-way ANOVA was performed to evaluate the effects of high-fat diet and G2019S LRRK2 and their interaction by Fisher’s LSD comparisons. Significant main and interaction effects were found (* P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001).
Article Snippet: Primary antibodies used for Western blotting include:
Techniques: Staining, Immunostaining, Knock-In, Quantitative Proteomics, Comparison, Analysis, Western Blot, Expressing, H&E Stain, Significance Assay
Journal: NPJ Parkinson's Disease
Article Title: Interaction of G2019S LRRK2 and metabolic syndrome in a two-hit mouse model of Parkinson’s disease: LRRK2-driven systemic depletion of pyrimidine nucleosides
doi: 10.1038/s41531-026-01465-x
Figure Lengend Snippet: Thymidine phosphorylase levels were significantly increased in the liver of G2019S LRRK2 knockin mice, leading to systemic depletion of pyrimidine nucleosides, which may contribute to mitochondrial dysfunction. Under control diet conditions, increased mitochondrial energy metabolism was observed in both brain and peripheral tissues of G2019S LRRK2 knockin mice, potentially reflecting a compensatory response to cellular stress or damage. High-fat diet exposure induced systemic metabolic dysregulation in G2019S LRRK2 knockin mice, accompanied by hepatic lipid accumulation, pulmonary inflammation, and neuroinflammatory responses in the brain. The combined effects of inflammation and the G2019S mutation revealed disruption of central carbon and nucleotide metabolism in the lung, as well as alterations in energy metabolism, decreased dopamine levels, and aberrant glial responses in the brain. Potential functional validation experiments, including metabolic cage analysis, Seahorse mitochondrial respiration assays, and stable isotope-labeled substrate tracing, would be informative.
Article Snippet: Primary antibodies used for Western blotting include:
Techniques: Knock-In, Control, Mutagenesis, Disruption, Functional Assay, Biomarker Discovery, Analysis, Labeling
Journal: Journal of Advanced Research
Article Title: HDAC2 enhances the antimicrobial activity of neutrophils by promoting the formation of neutrophil extracellular traps (NETs) in sepsis
doi: 10.1016/j.jare.2025.08.041
Figure Lengend Snippet: HDAC2 enhances antimicrobial activities against E.coli in mice. (A) Bacterial loads in the blood were calculated in HDAC2-knockout and wild type mice. (A)The picture of the bacterial clones was taken by BIO-RAD ChemiDoc“MP Imaging System. (B)The number of colony-forming units (CFU) in the blood of mice was calculated. HDAC2 WT and HDAC2 KO mice were administrated with E. coli- GFP (5 × 10 7 ) by intravenous Injection. Blood (20 μl) was taken from the tail vein of the mice, applied to the pretreated solid MHA medium, and incubated at 37 °C for 20 h. Count the colonies on the culture medium and take pictures. The experiments were performed in quintuplicate, data are presented as the means ± SEM. of independent experiments. *P < 0.05, **P < 0.01 (two-tailed Student’s t -test). (B) Bacterial loads in the kidneys were calculated in HDAC2-knockout and wild type mice. The picture of kidneys from HDAC2 WT and HDAC2 KO mice were taken. The number of colony-forming units (CFU) in the kidneys of mice was calculated. The kidneys from HDAC2 KO and HDAC2 WT mice were weighed, ground, spread on the MHA plates, incubated for 16–24 h at 37 °C, and then bacterial clones were counted. The experiments were performed in quintuplicate, data are presented as the means ± SEM. of independent experiments. *P < 0.05, **P < 0.01 (two-tailed Student’s t -test). n = 5 mice per group. (C) H&E staining of livers and kidneys. The arrows indicate damage section of tissue. (D) Serum CRP and PCT levels of mice with E. coli- GFP bacteremia at 24 h. The CRP and PCT were measured by ELISA. Data are shown as mean ± SEM. *p < 0.05; n = 5 mice per group. ns, not significant.
Article Snippet: Concentrations of interleukin-1 beta (IL-1β), interleukin-6 (IL-6), histone deacetylase 2 (HDAC2), PCT,
Techniques: Knock-Out, Clone Assay, Imaging, Injection, Incubation, Two Tailed Test, Staining, Enzyme-linked Immunosorbent Assay
Journal: Cells
Article Title: C-Terminus of Ca v 1.3 L-Type Ca 2+ Channel Upregulates Its Own Gene Expression
doi: 10.3390/cells15090828
Figure Lengend Snippet: The cleaved form of the Cav1.3-C-terminus is localized within the nucleus. ( A ) Schematic representation of the Cav1.3 α1 subunit with the four domains (I–IV), six repeat segments (1–6), pore region (P), N-terminus (brown), intracellular loops (IC, green) and the C-terminus (C-term, blue) with the relevant regulatory domains (Isoleucine-glutamine (IQ); EF-Helix binding motif (EF hand)). The commercial anti-II-III loop and anti-C-terminus antibodies’ epitope are shown in red. Anti-Ca v 1.3-C-terminus antibody labeling shows green fluorescent staining of the nucleus and the cytoplasm in ( B ) non-infected neonatal rat myocytes (NRVMs), ( E ) non-infected adult rat atrial myocytes (ARAMs) and ( H ) Ca v 1.3-transfected tsA201 cells. DAPI in blue ( C , F ) and red ( I ) is a nuclear staining marker. Arrows indicate nuclear staining. Overlay images are shown in ( D , G , J ). The scale bar is 20 μm. ( K ) Surface plot illustrating the staining intensity of the C-terminus in the nucleus and cytoplasm using the anti-C-terminus antibody. The central gray peak corresponds to nuclear green fluorescence. ( L ) Representative Western blots of nuclear and cyptoplasmic fractions from non-infected NRVMs and ARAMs probed with the C-terminus antibody (n = 5). Histone Deacetylase (HDAC) and Glyceraldehyde 3-Phosphate Dehydrogenase (GAPDH) were used as internal controls.
Article Snippet: Briefly, cardiac cells were fixed, permeabilized, blocked, and incubated overnight at 4 °C with a primary
Techniques: Binding Assay, Antibody Labeling, Staining, Infection, Transfection, Marker, Fluorescence, Western Blot, Histone Deacetylase Assay